4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)morpholine, 98%, 100mg

1-Methoxy-3-methylbutan-2-one, 97%, 500mg

1-Methyl-1H-1,2,3-triazole-4-carboxylic acid, 95.0%, 1g

1-(2-Bromo-ethyl)-2-fluoro-benzene, 95.0%, 5g

FMOC-(S)-3-AMINO-4-(4-METHOXY-PHENYL)-BUTYRIC ACID, 95%, 250mg

5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole, 97%, 100g

1-Cyclohexylethanol, 95.0%, 25g

Plantilla de nitrógeno con cono de vidrio esmerilado 14/23, 100 ml, 1 Pieza

2-(3-Methylphenyl)propan-2-amine, 97%, 100mg

3-Bromo-2-iodobenzonitrile, 98+%, 1g

beta-Nicotinamide Mononucleotide>98.0%(HPLC)50mg

DIMETHYLPROPIOTHETIN, 95%, 25g

(2S,3S,4S,5R,6S)-6-[(4,6-dihydroxy-5-oxo-2-phenyl-5H-chromen-7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 50g